The application of L-NAME to CHF rats significantly inhibited the elevating effects of salusin-β knockdown on NO levels and the depressing effects on NAD(P)H oxidase activity and ROS levels (Table 3). The gene discussed is FMO5; the disease is congestive heart failure.